Shift of microRNA profile upon glioma cell migration using patient-derived spheroids and serum-free conditions.

导出 OA

翻译打印收藏纠错

作者： Sune,Munthe ^[1] ; Bo,Halle ^[2] ; Henning B,Boldt ^[3] ; Helle,Christiansen ^[2] ; Steffen,Schmidt ^[3] ; Vivek,Kaimal ^[1] ; Jessica,Xu ^[4] ; Sonya,Zabludoff ^[5] ; Jan,Mollenhauer ^[6] ; Frantz R,Poulsen ^[6] ; Bjarne W,Kristensen ^[6]

作者单位： Department of Pathology, Odense University Hospital, Winsløwparken 15, 3rd floor, 5000, Odense C, Denmark. ^[1] Institute of Clinical Research, University of Southern Denmark, Winsløwparken 19, 5000, Odense C, Denmark. ^[2] Department of Neurosurgery, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark. ^[3] Department of Nuclear Medicine, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark. ^[4] Faculty of Health Sciences, Lundbeckfonden Center of Excellence NanoCAN and Molecular Oncology, Institute of Molecular Medicine, University of Southern Denmark, Winsløwparken 25, 5000, Odense C, Denmark. ^[5] Regulus Therapeutics, San Diego, CA, USA. ^[6] Department of Pathology, Odense University Hospital, Winsløwparken 15, 3rd floor, 5000, Odense C, Denmark. bjarne.winther.kristensen@rsyd.dk. ^[7] Institute of Clinical Research, University of Southern Denmark, Winsløwparken 19, 5000, Odense C, Denmark. bjarne.winther.kristensen@rsyd.dk. ^[8]

关键词 Glioblastoma MicroRNA Migration Serum-free Target